antidepressant treatment

Repressive Epigenetic Changes at the Mglu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice.

Published March 20, 2013

Repressive Epigenetic Changes at the Mglu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice.

Mol Pharmacol. 2013 Mar 18;
Kurita M, Moreno JL, Holloway T, Kozlenkov A, Mocci G, Garcia-Bea A, Hanks JB, Neve R, Nestler EJ, Russo SJ,… Continue reading →

IMPACT of CHILDHOOD ADVERSITY on the COURSE and SUICIDALITY of DEPRESSIVE DISORDERS: THE CRESCEND STUDY.

Published March 16, 2013

IMPACT OF CHILDHOOD ADVERSITY ON THE COURSE AND SUICIDALITY OF DEPRESSIVE DISORDERS: THE CRESCEND STUDY.

Depress Anxiety. 2013 Mar 11;
Kim SW, Kang HJ, Kim SY, Kim JM, Yoon JS, Jung SW, Lee MS, Yim HW, Jun TY

OBJECTIVE:… Continue reading →

Sociodemographic and Clinical Predictors of Compliance With Antidepressants for Depressive Disorders: Systematic Review of Observational Studies.

Published March 15, 2013

Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies.

Patient Prefer Adherence. 2013; 7: 151-69
Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, De Las Cuevas C

The literature shows that compliance… Continue reading →

How ‘person-centered’ Care Helped Guide Me Toward Recovery From Mental Illness.

Published March 7, 2013

How ‘person-centered’ care helped guide me toward recovery from mental illness.

Health Aff (Millwood). 2013 Mar; 32(3): 622-6
Clayton AR

A community psychiatry researcher reflects on the treatment she received in her youth for post-traumatic stress disorder and depression-and… Continue reading →

[Influence of Methylenetetrahydrofolate Reductase Gene Polymorphisms on Antidepressant Response].

Published March 3, 2013

[Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Feb; 30(1): 26-30
Sun X, Zhang Z, Shi Y, Xu Z, Pu M, Geng L

To assess the influence of polymorphisms… Continue reading →

Gene-Environment Interactions in Major Depressive Disorder.

Published February 28, 2013

Gene-environment interactions in major depressive disorder.

Can J Psychiatry. 2013 Feb; 58(2): 76-83
Klengel T, Binder EB

Family, twin, and epidemiologic studies have suggested that both genes and environment are important risk factors for the development of major depressive… Continue reading →

The Serotonergic System in Mood Disorders and Suicidal Behaviour.

Published February 28, 2013

The serotonergic system in mood disorders and suicidal behaviour.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120537
Mann JJ

A stress-diathesis explanatory model of suicidal behaviour has proved to be of heuristic value, and both clinical… Continue reading →

Neurobehavioral and Genotoxic Evaluation of (-)-Linalool in Mice.

Published February 27, 2013

Neurobehavioral and genotoxic evaluation of (-)-linalool in mice.

J Nat Med. 2013 Feb 24;
Coelho V, Mazzardo-Martins L, Martins DF, Santos AR, da Silva Brum LF, Picada JN, Pereira P

(-)-Linalool is a monoterpene compound commonly found as a… Continue reading →

Mental and Physical Health and Intimate Partner Violence Against Women: A Review of the Literature.

Published February 23, 2013

Mental and Physical Health and Intimate Partner Violence against Women: A Review of the Literature.

Int J Family Med. 2013; 2013: 313909
Dillon G, Hussain R, Loxton D, Rahman S

Associations between intimate partner violence (IPV) and poor physical… Continue reading →

Depression Treatment: Antidepressant Treatment and Emotional Processing: Can We Dissociate the Roles of Serotonin and Noradrenaline?

Published February 9, 2013

Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?

Filed under: Depression Treatment

J Psychopharmacol. 2013 Feb 7;
Pringle A, McCabe C, Cowen P, Harmer C

The ability to match individual patients to tailored… Continue reading →